U.S. pharma large copyright scrapped two experimental weight loss pills final yr—a the moment-every day capsule, lotiglipron, as a consequence of elevated liver enzymes along with a twice-every day capsule, danuglipron, as a result of sturdy Unintended effects—but CEO Albert Bourla has said the company is determined to “Participate in and win